New Blood Test for Cystic Fibrosis
Author Information
Author(s): Claudio Sorio, Mario Buffelli, Chiara Angiari, Michele Ettorre, Jan Johansson, Marzia Vezzalini, Laura Viviani, Mario Ricciardi, Genny Verzè, Baroukh Maurice Assael, Paola Melotti
Primary Institution: University of Verona, Italy
Hypothesis
Can a blood test be developed to evaluate CFTR expression and function in leukocytes for diagnosing cystic fibrosis?
Conclusion
The study successfully developed a blood test that can detect CFTR expression and function in monocytes, which may aid in diagnosing cystic fibrosis.
Supporting Evidence
- CFTR expression was detected in non-CF monocytes but was absent or truncated in CF patients.
- The CFTR index values were significantly lower in CF patients compared to non-CF and heterozygous groups.
- The nasal potential difference measurements correlated well with the monocyte assay results.
Takeaway
Researchers created a new blood test to check for a protein related to cystic fibrosis, which could help doctors diagnose the disease more easily.
Methodology
The study used Western blot, PCR, immunofluorescence, and cell membrane depolarization analysis to evaluate CFTR expression and function in monocytes.
Potential Biases
Potential bias in participant selection and the small sample size for certain groups.
Limitations
The test's ability to discriminate between heterozygous carriers and non-CF individuals was limited.
Participant Demographics
Participants included 31 non-CF individuals, 15 heterozygous carriers, and 44 cystic fibrosis patients, with a mix of genders and ages.
Statistical Information
P-Value
p<0.001
Confidence Interval
95%CI: 0.80–1.00
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website